Keynote Financial Services’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.01M Sell
12,332
-206
-2% -$48K 1.6% 13
2025
Q4
$2.59M Sell
12,538
-156
-1% -$30.8K 1.45% 13
2025
Q3
$2.35M Sell
12,694
-63
-0.5% -$10.8K 1.42% 13
2025
Q2
$1.95M Buy
12,757
+235
+2% +$36.1K 1.31% 18
2025
Q1
$2.08M Buy
12,522
+400
+3% +$62.6K 1.48% 14
2024
Q4
$1.75M Buy
12,122
+790
+7% +$122K 1.34% 16
2024
Q3
$1.84M Buy
11,332
+408
+4% +$65K 1.4% 13
2024
Q2
$1.6M Buy
10,924
+731
+7% +$109K 1.34% 18
2024
Q1
$1.61M Buy
+10,193
New +$1.62M 1.35% 16

Other funds holding JNJ

Keynote Financial Services's JNJ Position: Q1 2026 in Review

Keynote Financial Services reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q1 2026, selling an estimated $48K and leaving 12,332 shares worth $3.01M. The position accounts for 1.6% of the portfolio, ranked #13.

Keynote Financial Services first reported a position in JNJ in Q1 2024 and has held it in 9 quarters since. 4,614 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Keynote Financial Services held 12,332 shares of Johnson & Johnson worth $3.01M as of Q1 2026.
  • Keynote Financial Services sold 206 Johnson & Johnson shares in Q1 2026, an estimated $48K.
  • Johnson & Johnson made up 1.6% of Keynote Financial Services's portfolio in Q1 2026, its #13 holding.
  • Keynote Financial Services first reported a position in Johnson & Johnson in Q1 2024 and has held it in 9 quarters since.
  • 4,614 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Keynote Financial Services's 13F filing for Q1 2026, filed 13 May 2026.